mHealth Intervention to Prevent Type 2 Diabetes Mellitus (Phase II Study)
preDIABETEXT
Development and Evaluation of a Low Intensity, Multifaceted, Digital Health Intervention to Prevent Type 2 Diabetes Mellitus in the Primary Care Setting: the PREDIABETEXT Study
1 other identifier
interventional
365
1 country
1
Brief Summary
The aim of this study is to develop and evaluate a low intensity, multifaceted, digital health intervention to prevent T2DM based on: i) the use of a system comprising mobile health (mHealth) technology integrated with electronic health records to send tailored text messages (SMSs) promoting lifestyle changes in people at risk of T2DM, and, ii) the provision of online education to primary healthcare workers about prediabetes management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 5, 2021
CompletedFirst Posted
Study publicly available on registry
November 8, 2021
CompletedStudy Start
First participant enrolled
December 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2023
CompletedAugust 23, 2024
August 1, 2022
1.5 years
October 5, 2021
August 22, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from Baseline Glycated Hemoglobin (HbA1C) at 6 months
Baseline and Postintervention (6 months)
Secondary Outcomes (26)
Change from Baseline Fasting blood glucose at 6 months
Baseline and Postintervention (6 months)
Change from Baseline Triglycerides at 6 months
Baseline and Postintervention (6 months)
Change from Baseline Total Cholesterol at 6 months
Baseline and Postintervention (6 months)
Change from Baseline low density cholesterol (LDL) at 6 months
Baseline and Postintervention (6 months)
Change from Baseline high density cholesterol (HDL) at 6 months
Baseline and Postintervention (6 months)
- +21 more secondary outcomes
Other Outcomes (3)
Number of eligible patients
Baseline
Recruitment rate
Baseline
Follow-up rate
Postintervention (6 months)
Study Arms (3)
Intervention A
EXPERIMENTALParticipants will receive Messaging Intervention
Intervention B
EXPERIMENTALParticipants will receive messaging intervention plus online education to their primary healthcare workers
Control
NO INTERVENTIONParticipants will receive usual care only, and their healthcare workers will not receive online education
Interventions
Participants will receive text messages (three per week) in their mobile phones during six months.
Primary healthcare workers will receive an online educacion about prediabetes. This intervention will aim at: 1) raising awareness about the importance of T2DM prevention; 2) increasing knowledge about effective strategies for diabetes prevention; 3) improving knowledge about brief counselling techniques; and, 4) enhancing communication skills.
Eligibility Criteria
You may qualify if:
- Registered in the Public Health Service of the Balearic Islands
- At risk of T2DM (HbA1c from 6% to 6.4% within the last 3 months or two consecutive values of fasting plasma glucose 110-125mg/dl within the last 12 months, or both)
- With access to a mobile device able to receive text messages.
You may not qualify if:
- People not able to read messages in Spanish
- Patients with severe mental conditions.
- Patients on an antidiabetic medication regime
- Pregnancy: currently or during the previous 12 months
- People planning to change healthcare centre during the intervention period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ignacio Ricci-Cabello
Palma de Mallorca, Balearic Islands, 07002, Spain
Related Publications (3)
Soriguer F, Goday A, Bosch-Comas A, Bordiu E, Calle-Pascual A, Carmena R, Casamitjana R, Castano L, Castell C, Catala M, Delgado E, Franch J, Gaztambide S, Girbes J, Gomis R, Gutierrez G, Lopez-Alba A, Martinez-Larrad MT, Menendez E, Mora-Peces I, Ortega E, Pascual-Manich G, Rojo-Martinez G, Serrano-Rios M, Valdes S, Vazquez JA, Vendrell J. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study. Diabetologia. 2012 Jan;55(1):88-93. doi: 10.1007/s00125-011-2336-9. Epub 2011 Oct 11.
PMID: 21987347BACKGROUNDChow CK, Redfern J, Hillis GS, Thakkar J, Santo K, Hackett ML, Jan S, Graves N, de Keizer L, Barry T, Bompoint S, Stepien S, Whittaker R, Rodgers A, Thiagalingam A. Effect of Lifestyle-Focused Text Messaging on Risk Factor Modification in Patients With Coronary Heart Disease: A Randomized Clinical Trial. JAMA. 2015 Sep 22-29;314(12):1255-63. doi: 10.1001/jama.2015.10945.
PMID: 26393848BACKGROUNDMira-Martinez S, Malih N, Angullo-Martinez E, Zamanillo-Campos R, Yanez AM, Bennasar-Veny M, Gomez-Juanes R, Konieczna J, Jimenez R, Serrano-Ripoll MJ, Fiol-deRoque MA, Leiva A, Galmes-Panades AM, Miralles-Xamena J, Vidal-Thomas MC, Gomez-Cobo C, Gervilla E, Ona-Gil JI, Ricci-Cabello I. A Multifaceted Digital Intervention for the Prevention of Type 2 Diabetes Mellitus in Primary Care (PREDIABETEXT): Cluster Randomized Trial. J Med Internet Res. 2025 Oct 9;27:e70981. doi: 10.2196/70981.
PMID: 41067715DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 5, 2021
First Posted
November 8, 2021
Study Start
December 1, 2021
Primary Completion
May 31, 2023
Study Completion
May 31, 2023
Last Updated
August 23, 2024
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- Data will be available from January 2023 onwards
- Access Criteria
- Upon a reasonable request, we will grant access to public organizations. The PI of the project will review the requests.
We will share all collected IPD after anonymization